Shellfish Poisoning, Paralytic

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Shellfish Poisoning, Paralytic trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

CompletedNot Applicable

NCT05247229

Prevention of Paralytic Shellfish Poisoning in Subsistence Shellfish Harvest Communities of Southeast Alaska

The purpose of this tribally co-led community-based participatory research in partnership with Sitka Tribe of Alaska was to help prevent Paralytic Shellfish Poi…

United States50 participantsStarted 2022-03-01

Treatment: Middle school education program

UnknownPhase 1/2

NCT05052398

Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy

Proof-of-concept study to assess the effects of gonyautoxins (PSP NEURO SERUM) on safety and tactile sensitivity on patients with chemotherapy-induced periphera…

Brazil52 participantsStarted 2021-01-14

Treatment: PSP NEURO SERUM, Placebo PSP NEURO SERUM

CompletedPhase 1/2

NCT04799041

Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study

This was an interventional, double-blind, placebo controlled, randomized, single dose, proof-of-concept study. It was a single-center clinical trial. The purpo…

Chile30 participantsStarted 2019-10-11

Treatment: GTX 2/3, Placebo